These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 31605161)

  • 21. [Guideline-conform psychiatric psychotherapeutic treatment for patients with schizophrenia : A normative evaluation of necessary personnel requirements].
    Mehl S; Falkai P; Berger M; Löhr M; Rujescu D; Wolff J; Kircher T
    Nervenarzt; 2016 Mar; 87(3):286-94. PubMed ID: 26820457
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Schizophrenia in 2020: Trends in diagnosis and therapy.
    Gaebel W; Zielasek J
    Psychiatry Clin Neurosci; 2015 Nov; 69(11):661-73. PubMed ID: 26011091
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Guideline compliance in the treatment of schizophrenic patients. Introduction of a computer-assisted treatment pathway].
    Godemann F; Blittersdorf K; Poschenrieder M; Klimitz H; Hauth I; Gutzmann H
    Nervenarzt; 2010 May; 81(5):584-93. PubMed ID: 20024526
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment.
    Lewis SW; Davies L; Jones PB; Barnes TR; Murray RM; Kerwin R; Taylor D; Hayhurst KP; Markwick A; Lloyd H; Dunn G
    Health Technol Assess; 2006 May; 10(17):iii-iv, ix-xi, 1-165. PubMed ID: 16707074
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Canadian Schizophrenia Guidelines: Schizophrenia and Other Psychotic Disorders with Coexisting Substance Use Disorders.
    Crockford D; Addington D
    Can J Psychiatry; 2017 Sep; 62(9):624-634. PubMed ID: 28886671
    [TBL] [Abstract][Full Text] [Related]  

  • 26. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 2: update 2012 on the long-term treatment of schizophrenia and management of antipsychotic-induced side effects.
    Hasan A; Falkai P; Wobrock T; Lieberman J; Glenthoj B; Gattaz WF; Thibaut F; Möller HJ;
    World J Biol Psychiatry; 2013 Feb; 14(1):2-44. PubMed ID: 23216388
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The German S3 guidelines on prevention of coercion and treatment of aggressive behavior: from evidence to consensus, from consensus to implementation].
    Steinert T; Hirsch S
    Nervenarzt; 2023 Jul; 94(7):614-618. PubMed ID: 36939857
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of atypical antipsychotics on quality of life in patients with schizophrenia.
    Awad AG; Voruganti LN
    CNS Drugs; 2004; 18(13):877-93. PubMed ID: 15521791
    [TBL] [Abstract][Full Text] [Related]  

  • 29. AACAP official action. Summary of the practice parameters for the assessment and treatment of children and adolescents with schizophrenia. American Academy of Child and Adolescent Psychiatry.
    American Academy of Child and Adolescent Psychiatry
    J Am Acad Child Adolesc Psychiatry; 2000 Dec; 39(12):1580-2. PubMed ID: 11128338
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A prospective, multicenter, randomized, parallel-group, open-label study of aripiprazole in the management of patients with schizophrenia or schizoaffective disorder in general psychiatric practice: Broad Effectiveness Trial With Aripiprazole (BETA).
    Tandon R; Marcus RN; Stock EG; Riera LC; Kostic D; Pans M; McQuade RD; Nyilas M; Iwamoto T; Crandall DT
    Schizophr Res; 2006 May; 84(1):77-89. PubMed ID: 16483745
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Health management of older persons with chronically medicated psychotic disorders: the results of a survey in France.
    Arbus C; Clement JP; Bougerol T; Fremont P; Lancrenon S; Camus V
    Int Psychogeriatr; 2012 Mar; 24(3):496-502. PubMed ID: 21835072
    [TBL] [Abstract][Full Text] [Related]  

  • 32. German Guidelines on Screening, Diagnosis, and Treatment of Alcohol Use Disorders: Update 2021.
    Kiefer F; Batra A; Petersen KU; Ardern IS; Tananska D; Bischof G; Funke W; Lindenmeyer J; Mueller S; Preuss UW; Schäfer M; Thomasius R; Veltrup C; Weissinger V; Wodarz N; Wurst FM; ; Hoffmann S
    Eur Addict Res; 2022; 28(4):309-322. PubMed ID: 35439764
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of evidence grades in psychiatry and psychotherapy guidelines.
    Löhrs L; Handrack M; Kopp I; Jessen F; Wagner E; Falkai P; Röh A; Strube W; Hasan A
    BMC Psychiatry; 2020 Oct; 20(1):503. PubMed ID: 33046040
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Implementation of the German S3 guidelines on dementia in clinical practice: wish or reality?].
    Lohmann H; Kulessa F; Holling H; Johnen A; Reul S; Lueg G; Duning T
    Nervenarzt; 2017 Aug; 88(8):895-904. PubMed ID: 28429077
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The German S3 guidelines on dementia].
    Jessen F; Bohr L; Kruse C; Dodel R
    Nervenarzt; 2023 Jul; 94(7):609-613. PubMed ID: 37233772
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Symptomatic presentation and initial treatment for schizophrenia in children and adolescents.
    Correll CU
    J Clin Psychiatry; 2010 Nov; 71(11):e29. PubMed ID: 21114942
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antipsychotic medication use patterns and associated costs of care for individuals with schizophrenia.
    Loosbrock DL; Zhao Z; Johnstone BM; Morris LS
    J Ment Health Policy Econ; 2003 Jun; 6(2):67-75. PubMed ID: 14578539
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Assessing beliefs and attitudes of relatives of patients with schizophrenia: a study in a Tunisian sample].
    Bouhlel S; Ben Haouala S; Klibi A; Ghaouar M; Chennoufi L; Melki W; El-Hechmi Z
    Encephale; 2013 Jun; 39(3):165-73. PubMed ID: 23095602
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TAILOR - tapered discontinuation versus maintenance therapy of antipsychotic medication in patients with newly diagnosed schizophrenia or persistent delusional disorder in remission of psychotic symptoms: study protocol for a randomized clinical trial.
    Stürup AE; Jensen HD; Dolmer S; Birk M; Albert N; Nielsen M; Hjorthøj C; Eplov L; Ebdrup BH; Mors O; Nordentoft M
    Trials; 2017 Sep; 18(1):445. PubMed ID: 28962668
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Rationale for the use of long-acting injectable risperidone: a survey of French psychiatrists].
    Misdrahi D; Delgado A; Bouju S; Comet D; Chiariny JF
    Encephale; 2013 May; 39 Suppl 1():S8-14. PubMed ID: 23541914
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.